China Unveils Latest Five-Year Plans For Biopharma And Medical Device Industries (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
China’s ambitious five-year plans will support policies to increase domestic R&D and import substitution for China’s biopharma and medical device industries.